Related Experiment Video
Updated: Mar 18, 2026
08:35
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
4.4K
Interventional procedures and future drug therapy for hypertension
Melvin D Lobo1,2, Paul A Sobotka3,4, Atul Pathak5
1Barts BP Centre of Excellence, Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
European Heart Journal
|July 14, 2016
Summary
Managing hypertension remains challenging. New interventional procedures offer hope for patients with uncontrolled blood pressure (BP) or drug intolerance, complementing traditional drug therapies.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Clinical Pharmacology
Background:
- Effective hypertension management is crucial globally, yet non-drug measures often fail.
- Poor blood pressure (BP) control persists despite available drug therapies, highlighting unmet clinical needs.
- Non-adherence to antihypertensive medications due to side effects is a significant barrier to treatment success.
Purpose of the Study:
- To review novel interventional procedures for hypertension management.
- To evaluate the safety and efficacy of emerging antihypertensive technologies.
- To discuss the role of interventions for patients intolerant to or unresponsive to medication.
Main Methods:
- Review of current literature on interventional hypertension management.
- Analysis of emerging devices targeting sympathetic nervous system and mechanical circulatory aspects.
- Assessment of early safety and efficacy data from clinical studies.
Main Results:
- Novel interventional procedures are emerging as treatment options for resistant hypertension.
- These interventions target both neurogenic and mechanical factors influencing blood pressure.
- Early data suggest promising safety and efficacy profiles for these new technologies.
Conclusions:
- Interventional procedures represent a promising new frontier in hypertension management.
- Further rigorous randomized controlled trial data are essential for establishing these as standard care.
- These approaches offer alternatives for patients with medication intolerance or inadequate BP control.
Keywords:
Arteriovenous anastomosisBaroreflex activationDrug therapyHypertensionRenal denervationSympathetic nervous systemMore Related Videos
Related Concept Videos
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
819
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
819
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
01:30Heart Failure V: Medical Management
470
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
470
01:22Heart Failure VI: Adjunct Therapies
511
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
511
01:27Coronary Artery Disease V: Interprofessional Care
373
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
373
01:26Atherosclerosis III: Management
567
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567